Lovenox harga

lovenox harga

Pengertian Lovenox Lovenox adalah obat yang mengandung enoxaparin sodium. Obat ini digunakan untuk mencegah deep vein thrombosis (DVT) atau trombosis vena dalam serta mengatasi DVT akut.

Selain itu, obat ini dapat mencegah komplikasi angina tidak stabil dan infark miokard lovenox harga. Keterangan Lovenox Berikut adalah keterangan Lovenox, mulai dari golongan obat hingga harga: • Golongan: Obat Keras. • Kelas Terapi: Antikoagulan, Antiplatelet, dan Fibrinolitik (Trombolitik). • Kandungan: Enoxaparin Sodium 10.000 IU/mL. • Bentuk: Injeksi. • Satuan Penjualan: Satuan Syringe.

• Kemasan: Box, 2 Prefilled Syringe @ 0,2 mL; Box, 2 Prefilled Syringe @ 0,4 mL; Box, 2 Prefilled Syringe @ 0,6 mL. • Farmasi: Sanofi Winthrop/Aventis Pharma.

lovenox harga

• Harga Lovenox 0.6 ml: Rp. 165.000 - Rp. 300.000/Pcs. • Harga Lovenox 0.4 ml: Rp. 225.000 - Rp. 300.000/Pcs. Artikel Lainnya: Lakukan Ini agar Anda Terhindar dari Risiko DVT Kegunaan Lovenox Lovenox digunakan untuk mencegah tromboembolik vena, terutama pada bedah ortopedi atau lovenox harga umum pada pasien berisiko tinggi.

Dosis & Cara Penggunaan Lovenox Lovenox merupakan obat keras yang memerlukan resep dokter. Secara umum, dosis dan aturan penggunaan obat Lovenox adalah sebagai berikut: • Pencegahan DVT dalam pembedahan • Dosis pada pasien lovenox harga risiko trombogenik sedang: 0.2 mL/hari. • Dosis pada pasien dengan risiko trombogenik tinggi: 0.4 mL/hari. • Pencegahan DVT pada pasien dengan masalah kesehatan yang akut lovenox harga Dosis: 0,4 mL/hari selama 6-14 hari.

• Pencegahan pembekuan darah saat hemodialisis • Dosis awal: 100 anti-Xa IU/kg. • Dosis tambahan: 50-100 anti-Xa IU/kgBB. • Pasien hemodialisis dengan risiko tinggi • Dosis: 50 anti-Xa IU/kgBB (akses vaskular ganda) atau 75 anti-Xa IU/kgBB (akses vaskular tunggal).

• ST segmen evelasi infark miokard akut • Dosis awal 3.000 bolus anti-Xa IU, dilanjutkan dengan 100 anti-Xa IU/kg. • Dosis maksimal: 10.000 anti-Xa IU. • Pasien yang menjalani terapi angioplasti koroner • Dosis: 30 bolus anti-Xa IU/kg. • Dosis lansia ≥ 75 tahun: 75 anti-Xa IU/kgBB. • DVT dengan atau tanpa emboli paru • Dosis untuk pasien 40-100 kg: 100 anti-Xa IU/kg selama 10 hari. • Dosis pada angina tidak stabil & infark miokard non-q wave: 1 mg/kg tiap 12 jam.

Cara Penyimpanan Lovenox Di bawah 25 derajat Celsius. Artikel Lainnya: Lewat Kaki, Anda Bisa Mengetahui Masalah pada Tubuh Efek Samping Lovenox Efek samping yang dapat muncul selama penggunaan Lovenox, yaitu: • Nyeri. • Kemerahan.

lovenox harga

• Edema. • Pendarahan. • Trombositosis. • Peningkatan enzim hati. • Reaksi alergi. • Urtikaria. • Pruritus. Overdosis Penggunaan Lovenox yang melebihi anjuran dosis dapat menimbulkan komplikasi hemoragik.

Bila terjadi overdosis, tenaga medis dapat memberikan protamin secara injeksi intravena lambat. Kontraindikasi Hindari penggunaan Lovenox pada pasien dengan kondisi berikut: • Hipersensitivitas terhadap enoxaparin sodium dan heparin • Riwayat heparin-induced thrombocytopenia (HIT) dalam 100 hari terakhir.

• Perdarahan mayor aktif. Artikel Lainnya: Efek Gangguan Lovenox harga Darah pada Tubuh Interaksi Obat Berikut adalah interaksi Lovenox dengan obat lain: • Potensi risiko hiperkalemia dengan ACE & AIIA inhibitor, obat antiinflamasi nonsteroid (OAINS), tacrolimus, dan trimethoprim.

lovenox harga

• Peningkatan risiko hemoragik dengan asam asetilsalisilat pada dosis analgesik, antipiretik & antiinflamasi, ticlopidine, glucocorticoid, agen trombolitik, dan platelet aggregation inhibitor (PAI). Kategori Kehamilan Kategori B: Studi pada reproduksi hewan tidak menunjukkan adanya risiko terhadap janin. Namun, studi pada wanita hamil masih sangat terbatas. Peringatan Menyusui Tidak diketahui apakah Lovenox dapat terserap ke dalam ASI atau tidak. Konsultasikan terlebih dahulu kepada dokter.

Important Safety Information for Lovenox ® Warning: spinal/epidural hematomas Epidural or spinal hematomas may occur in patients who are anticoagulated with low molecular weight heparins (LMWH) or heparinoids and are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Sanofi US does not review the information contained on this website and/or database for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions set by the website and/or database producer.

This site might not comply with the regulatory requirements of US WARNING: SPINAL/EPIDURAL HEMATOMAS Epidural or spinal hematomas may occur in patients who are anticoagulated with low molecular weight heparins (LMWH) or heparinoids and are receiving neuraxial anesthesia or undergoing spinal puncture.

Lovenox harga hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include: • Use of indwelling epidural catheters • Concomitant use of other drugs that affect hemostasis, such as non-steroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, and other anticoagulants • A history of traumatic or repeated epidural or spinal punctures • A history of spinal deformity or spinal surgery • Optimal timing between the administration of Lovenox and neuraxial procedures is not known.

Monitor patients frequently for signs and symptoms of neurological impairment. If neurological compromise is noted, urgent treatment is necessary. Consider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated for thromboprophylaxis.

CONTRAINDICATIONS • Lovenox is contraindicated in patients with active major bleeding; history of heparin-induced thrombocytopenia (HIT) within lovenox harga past 100 days or in the presence of circulating antibodies; known hypersensitivity to enoxaparin sodium, heparin, pork products, lovenox harga benzyl alcohol (multi-dose formulation only).

lovenox harga

WARNINGS AND PRECAUTIONS • Lovenox should be used with extreme caution in conditions with increased risk of hemorrhage (eg. epidural or spinal anesthesia/analgesia or spinal puncture). While the exact timing is not known, the pharmacokinetic profile of Lovenox should be considered when determining the timing of placement/removal of an epidural catheter or lumbar puncture for each patient.

Major hemorrhages including retroperitoneal and intracranial bleeding have been reported. Some of these cases have been fatal. Bleeding can occur at any site during Lovenox therapy. An unexplained fall in hematocrit (HCT) or blood pressure should lead to a search for a bleeding site.

For patients with creatinine clearance <30 mL/min additional considerations are necessary. • For percutaneous coronary revascularization procedures, obtain hemostasis at the puncture site before sheath removal and observe the site for signs of bleeding or hematoma formation.

• In the STEMI population, the rates of major hemorrhages (defined as requiring 5 or more units of blood for transfusion, or 15% drop in HCT or clinically overt bleeding, including intracranial hemorrhage [ICH]) at 30 days were 2.1% in the Lovenox group and 1.4% in the unfractionated heparin (UFH) group. The rates of ICH at 30 days were 0.8% in the Lovenox group and 0.7% in the UFH group.

The 30-day rate of the composite endpoint of death, myocardial infarction, or ICH (a measure of net clinical benefit) was significantly lower in the Lovenox group (10.1%) compared to the UFH group (12.2%). • Lovenox should be used with caution in patients with bleeding diathesis, uncontrolled arterial hypertension or a history of recent gastrointestinal ulceration, diabetic retinopathy, renal dysfunction, or hemorrhage.

• Lovenox may cause Heparin-Induced Thrombocytopenia (HIT) or Heparin-Induced Thrombocytopenia with Thrombosis (HITTS). HITTS may lead to organ infarction, limb ischemia, or death. Monitor thrombocytopenia of any degree closely. Use of Lovenox in patients with a history of heparin-induced thrombocytopenia (HIT) within the past 100days or in the presence of circulating antibodies is contraindicated.

Lovenox harga antibodies may persist for several years. Because HIT may still occur in these circumstances, the decision to use Lovenox in such a case must be made only after a careful benefit-risk assessment lovenox harga after non-heparin alternative treatments are considered. • Thrombocytopenia can occur with Lovenox. Thrombocytopenia of any degree should be monitored closely.

If the platelet count falls below 100,000/mm3, Lovenox should be discontinued. • Lovenox cannot be used interchangeably with other LMWH or UFH, as they differ in their manufacturing process, molecular weight distribution, anti-Xa and anti-IIa activities, units, and dosages. • Use of Lovenox for thromboprophylaxis in pregnant women with mechanical prosthetic heart valves may result in valve lovenox harga.

Women with mechanical prosthetic heart valves may be at higher risk for thromboembolism during pregnancy and, when pregnant, have a higher rate of fetal loss from stillbirth, spontaneous abortion, and premature delivery.

Frequent monitoring of anti-Factor Xa levels and adjusting of dosage may be needed. • Serious and fatal adverse reactions including "gasping syndrome" can occur in neonates and low birth weight infants treated with benzyl alcohol–preserved drugs, including Lovenox multiple–dose vials.

• Periodic complete blood counts, including platelet count, and stool occult blood tests are recommended during the course of treatment with Lovenox harga. ADVERSE REACTIONS • Most common adverse reactions (>1%) were bleeding, anemia, thrombocytopenia, elevation of serum aminotransferase, diarrhea, nausea, ecchymosis, fever, edema, peripheral edema, dyspnea, confusion, and injection site pain. Indications Prophylaxis of deep vein thrombosis Lovenox is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism: • In patients undergoing abdominal surgery who are at risk for thromboembolic complications • In patients undergoing hip-replacement surgery, during and following hospitalization • In patients undergoing knee-replacement surgery • In medical patients who are at risk for thromboembolic complications due to severely restricted mobility during acute illness Treatment of Acute Deep Vein Thrombosis Lovenox is indicated for: • The inpatient treatment of acute deep vein thrombosis with or without pulmonary embolism, when administered in conjunction with warfarin sodium • The outpatient treatment of acute deep vein thrombosis without pulmonary embolism when administered in conjunction with warfarin sodium Prophylaxis of Ischemic Complications of Unstable Angina and Non-Q-wave Myocardial Infarction Lovenox is indicated for the prophylaxis of ischemic complications of unstable angina (UA) and non–Q-wave MI, when concurrently administered with aspirin.

lovenox harga

Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) Lovenox, when administered concurrently with aspirin, has been shown to reduce the rate of the combined endpoint of recurrent myocardial infarction (MI) or death in patients with acute ST-segment elevation MI (STEMI) receiving thrombolysis and being managed medically or with percutaneous coronary intervention (PCI).

Please see full Prescribing Information, including boxed WARNING. For more information, contact your local sanofi-aventis U.S. Representative or call sanofi-aventis U.S. Medical Information Services at 1-800-633-1610. Prescription Lovenox is available in pharmacies.

lovenox harga

Click here for information on Sharps Medical Waste Disposal. WARNING: SPINAL/EPIDURAL HEMATOMAS Epidural or spinal lovenox harga may occur in patients who are anticoagulated with low molecular weight heparins (LMWH) or heparinoids and are receiving neuraxial anesthesia or undergoing spinal puncture.

These hematomas may result in long-term or permanent paralysis. Consider lovenox harga risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include: • Use of indwelling epidural catheters • Concomitant use of other drugs that affect hemostasis, such as non-steroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, and other anticoagulants • A history of traumatic or repeated epidural or spinal punctures • A history of spinal deformity or spinal surgery • Optimal timing between the administration of Lovenox and neuraxial procedures is not known.

Monitor patients frequently for signs and symptoms of neurological impairment. If neurological compromise is noted, urgent treatment is necessary. Consider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated for thromboprophylaxis. CONTRAINDICATIONS • Lovenox is contraindicated in patients with active major bleeding; history of heparin-induced thrombocytopenia (HIT) within the past 100 days or in the presence of circulating antibodies; known hypersensitivity to enoxaparin sodium, heparin, pork products, or benzyl alcohol (multi-dose formulation only).

WARNINGS AND PRECAUTIONS • Lovenox should be used with extreme caution in conditions with increased risk of hemorrhage (eg. epidural or spinal anesthesia/analgesia or spinal puncture). While the exact timing is not known, the pharmacokinetic profile of Lovenox should be considered when determining the timing of placement/removal of an epidural catheter or lumbar puncture for each patient.

Major hemorrhages including retroperitoneal and intracranial bleeding have been reported. Some of these cases have been fatal. Bleeding can occur at any site during Lovenox therapy. An unexplained fall in hematocrit (HCT) or blood pressure should lead to a search for a bleeding site. For patients with creatinine clearance <30 mL/min additional considerations are necessary.

• For percutaneous coronary revascularization procedures, obtain hemostasis at the puncture site before sheath removal and observe the site for signs of bleeding or hematoma formation. • In the STEMI population, the rates of major hemorrhages (defined as requiring 5 or more units of blood for transfusion, or 15% drop in HCT or clinically overt bleeding, including intracranial hemorrhage [ICH]) at 30 days were 2.1% in the Lovenox group and 1.4% in the unfractionated heparin (UFH) group.

The rates of ICH at 30 days were 0.8% in the Lovenox group and 0.7% in the UFH group. The 30-day lovenox harga of the composite endpoint of death, myocardial infarction, or ICH (a measure of net clinical benefit) was significantly lower in the Lovenox group (10.1%) compared to the UFH group (12.2%).

• Lovenox should be used with caution in patients with bleeding diathesis, uncontrolled arterial hypertension or a history of recent gastrointestinal ulceration, diabetic retinopathy, renal dysfunction, or hemorrhage. • Lovenox may cause Heparin-Induced Thrombocytopenia (HIT) or Heparin-Induced Thrombocytopenia with Thrombosis (HITTS).

HITTS may lead to organ infarction, limb ischemia, or death.

lovenox harga

Monitor thrombocytopenia of any degree closely. Use of Lovenox in patients with a history of heparin-induced thrombocytopenia (HIT) within the past 100days or in the presence of circulating antibodies is contraindicated. Circulating antibodies may persist for several years. Because HIT may still occur in these circumstances, the decision to use Lovenox in such a case must be made only after a careful benefit-risk assessment and after non-heparin alternative treatments are considered.

• Thrombocytopenia can occur with Lovenox. Thrombocytopenia of any degree should be monitored closely. If the platelet count falls below 100,000/mm3, Lovenox should be discontinued. • Lovenox cannot be used interchangeably with other LMWH or UFH, as they differ in their manufacturing process, molecular weight distribution, anti-Xa and anti-IIa activities, units, and dosages.

• Use of Lovenox for thromboprophylaxis in pregnant women with mechanical prosthetic heart valves may result in valve thrombosis. Women with mechanical prosthetic heart valves may be at higher risk for thromboembolism during pregnancy and, when pregnant, have a higher rate of fetal loss from stillbirth, spontaneous abortion, and premature delivery.

Frequent monitoring of anti-Factor Xa levels and adjusting of dosage may be needed. • Serious and fatal adverse reactions including "gasping syndrome" can occur in neonates and low birth weight infants treated with benzyl alcohol–preserved drugs, including Lovenox multiple–dose vials. • Periodic complete blood counts, including platelet count, and stool occult blood tests are recommended during the course of treatment with Lovenox.

ADVERSE REACTIONS • Most common adverse reactions (>1%) were bleeding, anemia, thrombocytopenia, elevation of serum aminotransferase, diarrhea, nausea, ecchymosis, fever, edema, peripheral edema, dyspnea, confusion, and injection site pain.

Indications Prophylaxis of deep vein thrombosis Lovenox is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism: • In patients undergoing abdominal surgery who are at risk for thromboembolic complications • In patients undergoing hip-replacement surgery, during and following hospitalization • In patients undergoing knee-replacement surgery lovenox harga In medical patients who are at risk for thromboembolic complications due to severely restricted mobility during acute illness Treatment of Acute Deep Vein Thrombosis Lovenox is indicated for: • The inpatient treatment of acute deep vein thrombosis with or without pulmonary embolism, when administered in conjunction with warfarin sodium • The outpatient treatment of acute deep vein thrombosis without pulmonary embolism when administered in conjunction with warfarin sodium Prophylaxis of Ischemic Complications of Unstable Angina and Non-Q-wave Myocardial Infarction Lovenox is indicated for the prophylaxis of ischemic complications of unstable angina (UA) and non–Q-wave MI, when concurrently administered with aspirin.

Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) Lovenox, when administered concurrently with aspirin, has been shown to reduce the rate of the combined endpoint of recurrent myocardial infarction (MI) or death in patients with acute ST-segment elevation MI (STEMI) receiving thrombolysis and being managed medically or with percutaneous coronary intervention (PCI).

Please see full Prescribing Information, including boxed WARNING. For more information, contact your local sanofi-aventis U.S. Representative or call sanofi-aventis U.S. Medical Information Services at 1-800-633-1610. Prescription Lovenox is available in pharmacies. Click here for information on Sharps Medical Waste Disposal.

Reference s: • Lovenox [prescribing information]. Bridgewater, NJ: sanofi-aventis; 2013. • Lovenox® (enoxaparin lovenox harga injection) Prescribing Information. sanofi-aventis, Bridgewater, NJ. • ENOXACAN Study Group. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.

Br J Surg. 1997;84(8):1099-1103. • Heparin Sodium Injection, Prescribing Information. New York, NY: Pfizer; 2016. • Merli G, Spiro TE, Olsson C-G, et al; Enoxaparin Clinical Trial Group. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med.

2001;134(3):191-202. • Levine M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

N Engl J Med. 1996;334(11):677-681. • Antman EM, Morrow DA, McCabe CH, et al; ExTRACT-TIMI 25 Investigators. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med.

2006;354(14):1477-1488. • Antman EM, Morrow DA, McCabe CH, et al; ExTRACT-TIMI 25 Investigators. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction: design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Lovenox harga Infarction Treatment- Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25). Am Heart J. 2005;149(2):217-226. • Data on file, sanofi-aventis, Bridgewater, NJ.

• Lovenox [prescribing information]. Bridgewater, NJ: sanofi-aventis; 2013. • Cohen M, Demers C, Gurfinkel EP, et al; Efficacy and Safety of Lovenox harga Enoxaparin in Non–Q-Wave Lovenox harga Events Study Group.

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med. 1997;337(7):447-452. • Data on file, sanofi-aventis, Bridgewater, NJ. • Goodman SG, Cohen M, Bigonzi F, et al; Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q Wave Coronary (ESSENCE) Study Group. Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year lovenox harga of the ESSENCE study.

J Am Coll Cardiol. 2000;36(3):693-698. • Lovenox harga EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64:e139–228. • Antman EM, Morrow DA, McCabe CH, et al; ExTRACT-TIMI 25 Investigators.

Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med. 2006;354(14):1477-1488. • Antman EM, Morrow DA, McCabe CH, et al; ExTRACT-TIMI 25 Investigators. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).

Am Heart J. 2005;149(2):217-226. • O’Gara PT, Kushner FG, Ascheim DD, et al; American College of Emergency Physicians; Society for Cardiovascular Angiography lovenox harga Interventions 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

J Am Coll Cardiol. 2013;61(4):e78 –140, doi:10.1016/j.jacc.2012.11.019. • Lovenox [prescribing information]. Bridgewater, NJ: sanofi-aventis; 2013.

• U.S. Dept of Health and Human Services. 2015 CMS statistics. Accessed at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/CMS-Statistics-Reference-Booklet/Downloads/2015CMSStatistics.pdf on September 12, 2017. • Antman EM, Lovenox harga DA, McCabe CH, et al; ExTRACT-TIMI 25 Investigators. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction.

N Engl J Med. 2006;354(14):1477-1488. • Lovenox [prescribing information]. Bridgewater, NJ: sanofi-aventis; 2013. • US Department of Health and Human Services. 2015 CMS statistics. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/CMS-Statistics-Reference-Booklet/Downloads/2015CMSStatistics.pdf. Accessed on September 12, 2017.

Lovenox is available by prescription only. © 2002-2019 sanofi-aventis U.S. LLC. All rights reserved. Legal Disclaimer - Privacy Policy - Contact Sanofi For more information, Contact Medical Information This site is intended for use by U.S.

Healthcare Professionals only. SAUS.ENO.17.09.7179(2) Last Update: May 2019
GoodRx - Error Stop paying too much for your prescriptions Thanks for visiting! GoodRx is not available outside of the United States. If you are trying to access this site from the United States and believe you have received this message in error, please reach out to legal@goodrx.com and let us know. Lovenox Prices, Coupons and Patient Assistance Programs Lovenox (enoxaparin) is a member of the heparins drug class and is commonly used for Acute Coronary Syndrome, Angina, Deep Vein Thrombosis, and others.

Lovenox Prices The cost for Lovenox injectable solution (30 mg/0.3 mL) is around $77 for a supply of 3 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Drugs.com Printable Discount Card The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies lovenox harga. Lovenox Coupons and Rebates Lovenox offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

lovenox harga

There are currently no Manufacturer Promotions that we know about for this drug. Patient Assistance Programs for Lovenox Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for lovenox harga program.

Provider: Sanofi Patient Connection Elligibility requirements: • Must have no prescription coverage for needed medication • At or below 400% of FPL • Medically appropriate condition/diagnosis • Must be residing in the US or a US territory, and under the care lovenox harga a US physician • Healthcare provider must contact the Program for REORDER FORMS.

Applicable drugs: • Lovenox (enoxaparin sodium) Injection More information please phone: 888-847-4877 Visit Website More about Lovenox (enoxaparin) • Side effects • Drug interactions • Dosage information • During pregnancy or Breastfeeding • Reviews (18) • Compare alternatives • Generic availability • En español • Drug class: heparins • Latest FDA Alerts (5) Patient resources • Drug Information • Lovenox (Advanced Reading) • Lovenox (Enoxaparin Injection) • Lovenox (Enoxaparin Multi-Dose Vials) Professional resources • Prescribing Information Related treatment guides • Deep Vein Thrombosis • Angina • Deep Vein Thrombosis Prophylaxis after Abdominal Surgery • Acute Coronary Syndrome Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products.

This material is provided for educational purposes only and is not intended for medical advice, lovenox harga or treatment. Data sources include IBM Watson Micromedex (updated 3 May 2022), Cerner Multum™ (updated 28 Apr 2022), ASHP (updated 11 Apr 2022) and others.
Daftar Isi • Apa Kandungan dan Komposisi Lovenox? • Lovenox Obat Apa? • Apa Indikasi, Manfaat, dan Kegunaan Lovenox?

• Apa Saja Kontraindikasi Lovenox? • Apa saja Perhatian Penggunaan Lovenox? lovenox harga Pertanyaan yang Sering Diajukan • Apa Efek Samping Lovenox?

• Apa Saja Interaksi Obat Lovenox? • Bagaimana Kategori Keamanan Penggunaan Lovenox Pada Wanita Hamil? • Berapa Dosis dan Bagaimana Aturan Pakai Lovenox?

• Sediaan, Kemasan, Harga Lovenox? • Apa Nama Perusahaan Produsen Lovenox? Apa Kandungan dan Komposisi Lovenox? Kandungan dan komposisi produk obat maupun suplemen dibedakan menjadi dua jenis yaitu kandungan aktif dan kandungan tidak aktif. Kandungan aktif adalah zat yang dapat menimbulkan aktivitas farmakologis atau efek langsung dalam diagnosis, pengobatan, terapi, pencegahan penyakit atau untuk memengaruhi struktur atau fungsi dari tubuh manusia.Jenis yang kedua adalah kandungan tidak aktif atau disebut juga sebagai eksipien.

Kandungan tidak aktif ini fungsinya sebagai media atau agen transportasi untuk mengantar atau mempermudah kandungan aktif untuk bekerja. Kandungan tidak aktif tidak akan menambah atau meningkatkan efek terapeutik dari kandungan aktif. Beberapa contoh dari kandungan tidak aktif ini antara lain zat pengikat, zat penstabil, zat pengawet, zat pemberi warna, dan zat pemberi rasa. Kandungan dan komposisi Lovenox adalah: Enoxaparin Na.

Lovenox Obat Apa? Apa Indikasi, Manfaat, dan Kegunaan Lovenox? Indikasi merupakan petunjuk mengenai kondisi medis yang memerlukan efek terapi dari suatu produk kesehatan (obat, suplemen, dan lain-lain) atau kegunaan dari suatu produk kesehatan untuk suatu kondisi medis tertentu. Lovenox adalah suatu produk kesehatan yang diindikasikan untuk: Profilaksis gangguan tromboembolik vena terutama pada bedah ortopedi atau bedah umum pada pasien berisiko tinggi.

Mencegah trombosis pada sirkulasi ekstrakorporal selama hemodialisa. Terapi angina tidak stabil & infark lovenox harga gelombang non-Q jika diberikan bersama dengan asetosal. Profilaksis penyakit tromboembolik vena pada pasien yang hrs berbaring terus di tempat tidur, dengan faktor risiko sedang sampai tinggi.

Apa Saja Kontraindikasi Lovenox? Kontraindikasi merupakan suatu petunjuk mengenai kondisi-kondisi dimana penggunaan obat tersebut tidak tepat atau tidak dikehendaki dan kemungkinan berpotensi membahayakan jika diberikan.

Pemberian Lovenox dikontraindikasikan pada kondisi-kondisi berikut ini: Riwayat trombositopenia selama terapi dengan enoksaparin. Kecenderungan perdarahan, lesi organik yang cenderung berdarah, endokarditis bakterial akut, gangguan pembekuan darah mayor, stroke, ulkus GI akut. Apa saja Perhatian Penggunaan Lovenox? Gangguan fungsi hati atau ginjal, hipertensi arterial yang tak terkontrol, riwayat tukak GI, kehamilan, laktasi, penyakit vaskular pada koroid & retina, pasca operasi otak & tulang belakang.

Riwayat trombositopenia dengan terapi heparin. Jangan diberikan secara IM. Pertanyaan yang Sering Diajukan Apakah Aman Menggunakan Lovenox Saat Mengemudi atau Mengoperasikan Mesin? Jika Anda mengalami gejala efek samping seperti mengantuk, pusing, gangguan penglihatan, gangguan pernapasan, jantung berdebar, dan lain-lain setelah menggunakanyang dapat mempengaruhi kesadaran atau kemampuan dalam mengemudi maupun mengoperasikan mesin, maka sebaiknya Anda menghindarkan diri dari aktivitas-aktivitas tersebut selama penggunaan dan konsultasikan dengan dokter Anda.

lovenox harga

Bagaimana Jika Saya Lupa Menggunakan Lovenox? Jika Anda lupa menggunakan Lovenox, segera gunakan jika waktunya belum lama terlewat, namun jika sudah lama terlewat dan mendekati waktu penggunaan berikutnya, maka gunakan seperti dosis biasa dan lewati dosis yang sudah terlewat, jangan menggandakan dosis untuk mengganti dosis yang terlewat.

Pastikan Anda mencatat atau menyalakan lovenox harga untuk mengingatkan Anda mengenai waktu penggunaan obat agar tidak terlewat kembali. Apakah Saya Dapat Menghentikan Penggunaan Lovenox Sewaktu-waktu? Beberapa obat harus lovenox harga sesuai dengan dosis yang diberikan oleh dokter.

Jangan melebih atau mengurangi dosis obat yang diberikan oleh dokter secara sepihak tanpa berkonsultasi dengan dokter. Obat seperti antibiotik, antivirus, antijamur, dan sebagainya harus digunakan sesuai petunjuk dokter untuk mencegah resistensi dari bakteri, virus, maupun jamur terhadap obat tersebut. Konsultasikan dengan dokter mengenai hal ini. Jangan menghentikan penggunaan obat secara tiba-tiba tanpa sepengetahuan dokter, karena beberapa obat memiliki efek penarikan jika penghentian dilakukan secara mendadak.

Konsultasikan dengan dokter mengenai hal ini. Bagaimana Cara Penyimpanan Lovenox?

lovenox harga

Setiap obat memiliki cara penyimpanan yang berbeda-beda, cara penyimpanan dapat Anda ketahui melalui kemasan obat. Pastikan Anda menyimpan obat pada tempat tertutup, jauhkan dari panas maupun kelembapan. Jauhkan juga dari paparan sinar Matahari, jangkauan anak-anak, dan jangkauan hewan.

Bagaimana Penanganan Lovenox yang Sudah Kedaluwarsa? Jangan membuang obat kedaluwarsa ke saluran air, tempat penampungan air, maupun toilet, sebab dapat berpotensi mencemari lingkungan.

Juga jangan membuangnya langsung ke tempat pembuangan sampah umum, hal tersebut untuk menghindari penyalahgunaan obat. Hubungi Dinas Kesehatan setempat mengenai cara penangangan obat kedaluwarsa. Apa Efek Samping Lovenox? Efek Samping merupakan suatu efek yang tidak diinginkan dari suatu obat. Efek samping ini dapat bervariasi pada setiap individu tergantung pada pada kondisi penyakit, usia, berat badan, jenis kelamin, etnis, maupun kondisi kesehatan seseorang.

Efek samping Lovenox lovenox harga mungkin terjadi adalah: Gejala perdarahan, trombositopenia. Jarang: hematoma & nekrosis kulit pada tempat injeksi; alergi pada kulit atau reaksi alergi sistemik. Apa Saja Interaksi Obat Lovenox?

Interaksi obat merupakan suatu perubahan aksi atau lovenox harga obat sebagai akibat dari penggunaan atau pemberian bersamaan dengan obat lain, suplemen, makanan, minuman, atau zat lainnya. Interaksi obat Lovenox antara lain: Meningkatkan resiko perdarahan: AINS, tiklopidin, kortikosteroid, dekstran 40. Meningkatkan efek antikoagulan oral.

Menghambat agregasi platelet, antagonis Vitamin Lovenox harga. Bagaimana Kategori Keamanan Penggunaan Lovenox Pada Wanita Hamil? Kategori keamanan penggunaan obat untuk wanita hamil atau pregnancy category merupakan suatu kategori mengenai tingkat keamanan obat untuk digunakan selama periode kehamilan apakah memengaruhi janin atau tidak. Kategori ini tidak termasuk tingkat keamanan obat untuk digunakan oleh wanita menyusui.FDA (Badan Pengawasan Obat lovenox harga Makanan Amerika Serikat) mengkategorikan tingkat keamanan obat untuk wanita hamil menjadi 6 (enam) kategori yaitu A, B, C, D, X, dan N.

Anda bisa membaca definisi dari setiap kategori tersebut di sini. Berikut ini kategori tingkat keamanan penggunaan Lovenox untuk digunakan oleh wanita hamil: Kategori B: Studi terhadap reproduksi pada binatang percobaan tidak memperlihatkan adanya risiko terhadap janin tetapi tidak ada studi terkontrol yang dilakukan terhadap wanita hamil, atau studi terhadap reproduksi binatang percobaan memperlihatkan adanya efek samping (selain penurunan fertilitas) yang tidak dikonfirmasikan dalam studi terkontrol pada wanita pada kehamilan trimester 1 (dan tidak ada bukti risio pada trimester selanjutnya).

lovenox harga

Berapa Dosis dan Bagaimana Aturan Pakai Lovenox? Dosis adalah takaran yang dinyatakan dalam satuan bobot maupun volume (contoh: mg, gr) produk kesehatan (obat, suplemen, dan lain-lain) yang harus digunakan untuk suatu kondisi medis tertentu serta frekuensi pemberiannya. Biasanya kekuatan dosis ini tergantung pada kondisi medis, usia, dan berat badan seseorang.

Aturan pakai mengacu pada bagaimana produk kesehatan tersebut digunakan atau dikonsumsi. Berikut ini dosis dan aturan pakai Lovenox: Mencegah tromboemboli sehari 20 mg SK pada pasien dengan risiko sedang & 40 mg/hari pada risiko tinggi. Pd bedah umum suntikan awal diberikan 2 jam sblm operasi. Pd bedah ortopedi suntikan awal hrs diberikan lovenox harga jam sblm operasi.

Lanjutkan pengobatan 7-10 hari stlh op. Hemodialisa 1 mg/kg BB ke dalam arteria dr sirkuit dialisa pada 4 jam awal. Fresh injeksi 0.5-1 mg/kg Lovenox harga hrs diberikan bila cincin fibrin terbentuk.

Terapi trombosis vena dlm 1 mg/kg SK 2 x/hari. Angina tidak stabil & infark miokard non-Q wave 1 mg/kg SK tiap 12 jam diberikan bersama asetosal oral 100-325 mg 1 x/hari. Terapi hrs diberikan min 2 hari s/d keadaan klinis stabil (biasanya 2-8 hr). Profilaksis pada pasien yang hrs berbaring terus di tempat tidur 4000 anti-Xa/0.4 mL 1 x/hari secara injeksi SK selama 6-14 hari. Sediaan, Kemasan, Harga Lovenox? • Lovenox injeksi 20 mg/0.2 mL, 0.2 mL x 2 × 1’s (Rp137,070/boks) • Lovenox injeksi 40 mg/0.4 mL, 0.4 mL x 2 × 1’s (Rp242,680/boks) • Lovenox injeksi 60 mg/0.6 mL, 0.6 mL x 2 × 1’s (Rp347,160/boks) Apa Nama Perusahaan Produsen Lovenox?

Produsen obat (perusahaan farmasi) adalah suatu perusahaan atau badan usaha yang melakukan kegiatan produksi, penelitian, pengembangan lovenox harga obat maupun produk farmasi lainnya. Obat yang diproduksi bisa merupakan obat generik maupun obat bermerek. Perusahaan jamu adalah suatu perusahaan yang memproduksi produk jamu yakni suatu bahan atau ramuan berupa tumbuhan, bahan hewan, bahan mineral, sari, atau campuran dari bahan-bahan tersebut yang telah digunakan secara turun-temurun untuk pengobatan.

Baik perusahaan farmasi maupun perusahaan jamu harus memenuhi persyaratan yang telah ditetapkan.Setiap perusahaan farmasi harus memenuhi syarat CPOB (Cara Pembuatan Obat yang Baik), sedangkan perusahaan jamu harus memenuhi syarat CPOTB (Cara Pembuatan Obat Tradisional yang Baik) untuk lovenox harga melakukan kegiatan produksinya agar produk yang dihasilkan dapat terjamin khasiat, keamanan, dan mutunya.

Berikut ini nama perusahaan pembuat produk Lovenox: Sanofi Aventis Leave a Reply Cancel reply Email address will not be published. Required fields are marked * Comment * Name * Email * Δ Category: Antikoagulan, Antiplatelet, & Fibrinolitik (Trombolitik) Tags: Enoxaparin natrium, Enoxaparin sodium, G, Sanovi Aventis Tags: Enoxaparin natrium, Enoxaparin sodium, G, Sanovi Aventis

BENTAR LAGI LAHIRAN , NANAS SUNTIK TIAP HARI




2022 www.videocon.com